These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11252324)

  • 1. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae.
    Ghosh AS; Kar AK; Kundu M
    J Antimicrob Chemother; 1999 Feb; 43(2):195-201. PubMed ID: 11252324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in high molecular mass penicillin-binding protein 1 associated with beta-lactam resistance in Shigella dysenteriae.
    Ghosh AS; Kar AK; Kundu M
    Biochem Biophys Res Commun; 1998 Jul; 248(3):669-72. PubMed ID: 9703984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    Sumita Y; Fukasawa M
    J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
    Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of a 43-kilodalton outer membrane protein in beta-lactam resistance of Shigella dysenteriae.
    Kar AK; Ghosh AS; Chauhan K; Ahamed J; Basu J; Chakrabarti P; Kundu M
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2302-4. PubMed ID: 9333070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactam antibiotics].
    Inoue M; Okamoto R
    Nihon Rinsho; 1990 Oct; 48(10):2178-83. PubMed ID: 2280461
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
    van Langevelde P; Kwappenberg KM; Groeneveld PH; Mattie H; van Dissel JT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):739-43. PubMed ID: 9559775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.
    Gehrlein M; Leying H; Cullmann W; Wendt S; Opferkuch W
    Chemotherapy; 1991; 37(6):405-12. PubMed ID: 1760939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenes.
    Pierre J; Boisivon A; Gutmann L
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1695-8. PubMed ID: 2126687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.
    Quinn JP; Dudek EJ; DiVincenzo CA; Lucks DA; Lerner SA
    J Infect Dis; 1986 Aug; 154(2):289-94. PubMed ID: 3088133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.
    Jackson JJ; Kropp H
    J Infect Dis; 1992 Jun; 165(6):1033-41. PubMed ID: 1583320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance.
    Fang H; Edlund C; Nord CE; Hedberg M
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S47-53. PubMed ID: 12173108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ; Drusano GL; Mobley HL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1892-6. PubMed ID: 3125787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G; Guan L; Fontana R; Satta G
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical perspectives on imipenem.
    Neu HC
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():149-53. PubMed ID: 6583196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.